QCMC
JAZZ icon

Quantum Capital Management (California)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Quantum Capital Management (California)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$83K Sell
585
-57
-9% -$7.07K 0.09% 130
2020
Q2 		$71K Sell
642
-91
-12% -$10.1K 0.04% 203
2020
Q1 		$73K Sell
733
-50
-6% -$6.46K 0.05% 201
2019
Q4 		$117K Sell
783
-11
-1% -$1.5K 0.06% 192
2019
Q3 		$102K Buy
+794
New +$106K 0.05% 214

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Quantum Capital Management (California)'s JAZZ Position: Q3 2020 in Review

Quantum Capital Management (California) reduced its Jazz Pharmaceuticals (JAZZ) stake by 8.9% in Q3 2020, selling an estimated $7.07K and leaving 585 shares worth $83K. The position accounts for 0.09% of the portfolio, ranked #130.

Quantum Capital Management (California) first reported a position in JAZZ in Q3 2019 and has held it in 5 quarters since. The position peaked at $117K in Q4 2019. 390 funds tracked by Wall St. Rank hold JAZZ as of Q3 2020.

  • Quantum Capital Management (California) held 585 shares of Jazz Pharmaceuticals worth $83K as of Q3 2020.
  • Quantum Capital Management (California) sold 57 Jazz Pharmaceuticals shares in Q3 2020, an estimated $7.07K.
  • Jazz Pharmaceuticals made up 0.09% of Quantum Capital Management (California)'s portfolio in Q3 2020, its #130 holding.
  • Quantum Capital Management (California) first reported a position in Jazz Pharmaceuticals in Q3 2019 and has held it in 5 quarters since.
  • Quantum Capital Management (California)'s Jazz Pharmaceuticals position peaked at $117K in Q4 2019.
  • 390 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2020.

Based on Quantum Capital Management (California)'s 13F filing for Q3 2020, filed 16 Nov 2020.